Menu

MedTech and Pharma News



US Oncologists See Biosimilars As An ‘Appealing Alternative’
US community oncology practices are keen to support biosimilar uptake. But they appreciate the need to educate physicians not only...
Scrip - April 23, 2019
Sandoz Seeks More Than £100m On UK Buprenorphine
Sandoz fears that Napp may not be able to meet its obligations on damages in a UK dispute over buprenorphine...
Scrip - April 23, 2019
New Thai Rules To Impact Drug Approvals And Licenses
Amendments to Thailand’s Drug Act will come into force in October.
Scrip - April 23, 2019
Making Sense Of The Muddle Of EU Device Registration Timelines
The recent document from the European Commission's Medical Devices Coordination Group concerning device registration timelines is difficult to follow, with...
Scrip - April 23, 2019
R&D Meets The Crowdscape: BioMed X Looks Outside For Insight
It is a cliché to say that pharma science loves to collaborate – the hard thing is that leaky decision...
IN VIVO - April 23, 2019
Japan's Healios Progresses Novel Cell Therapy For ARDS
Activity in Japan's cell and regenerative therapy space continues apace as venture starts trial with lead development asset for acute...
Scrip - April 23, 2019
QUOTED. April 23, 2019. Sen. Roy Blunt.
US legislators accuse the Chinese government of recruiting and subsidizing US NIH-funded Chinese researchers to steal US-owned genetic research and...
Scrip - April 23, 2019

QUOTED. April 22, 2019. Frans van Houten.
Philips' CEO Frans van Houten spoke about his vision for the company's continued adoption of machine learning and artificial intelligence...
Medtech Insight - April 22, 2019

US Oncologists See Biosimilars As An ‘Appealing Alternative’
US community oncology practices are keen to support biosimilar uptake. But they appreciate the need to educate physicians not only...
Scrip - April 23, 2019
Sandoz Seeks More Than £100m On UK Buprenorphine
Sandoz fears that Napp may not be able to meet its obligations on damages in a UK dispute over buprenorphine...
Scrip - April 23, 2019
New Thai Rules To Impact Drug Approvals And Licenses
Amendments to Thailand’s Drug Act will come into force in October.
Scrip - April 23, 2019
Making Sense Of The Muddle Of EU Device Registration Timelines
The recent document from the European Commission's Medical Devices Coordination Group concerning device registration timelines is difficult to follow, with...
Scrip - April 23, 2019
Japan's Healios Progresses Novel Cell Therapy For ARDS
Activity in Japan's cell and regenerative therapy space continues apace as venture starts trial with lead development asset for acute...
Scrip - April 23, 2019
QUOTED. April 23, 2019. Sen. Roy Blunt.
US legislators accuse the Chinese government of recruiting and subsidizing US NIH-funded Chinese researchers to steal US-owned genetic research and...
Scrip - April 23, 2019

HHS Rebate Reform: An Air Of Inevitability In Stakeholder Comments
Manufacturers, pharmacy benefit managers and insurers weigh in on the Trump administration’s most significant drug pricing action to date –...
The Pink Sheet - April 22, 2019

R&D Meets The Crowdscape: BioMed X Looks Outside For Insight
It is a cliché to say that pharma science loves to collaborate – the hard thing is that leaky decision...
IN VIVO - April 23, 2019

BI partners with Science 37 for the development of novel therapies
Boehringer Ingelheim GMBH licensed rights to Science 37 Inc.'s NORA (Network Oriented Research Assistant) proprietary software platform.
Strategic Transactions - January 9, 2019
Teva settles patent litigation with Neos; gets rights to market generic Cotempla XR
As part of a patent litigation settlement, Neos Therapeutics Inc. granted Teva Pharmaceuticals USA Inc. rights to manufacture and market a generic form of its Cotempla XR-ODT. Under the agreement, Teva may begin to manufacture and market the drug beginning on July 1, 2026 or earlier.
Strategic Transactions - January 9, 2019

Wellness Product Launches: Equelle For Menopause, Renadyl For Uremic Toxins, More
S-equol in Equelle menopause supplement; antioxidant support for PTSD symptoms; supplement targets uremic toxins; green tea for heart health; and...
The Rose Sheet - April 19, 2019
CBD Market: Vitamin Shoppe Enters Field, More Gummies Launched
Nutrition, health and wellness productfirm launches its CBD sales with Irwin's Naturals products and also offers SpaRoom oils. Green Gorilla...
The Rose Sheet - April 19, 2019
Canada Moving Toward Cosmetic Animal-Testing Ban Potentially Stricter Than California Law
The Cruelty-Free Cosmetics Act, S 214, would ban the sale of cosmetics developed with animal testing that’s conducted four years...
The Rose Sheet - April 19, 2019
Back to the top Back to the top